Treatments for pulmonary sarcoidosis

Respiratory Medicine

Volumn 102, Issue 1, 2008, Pages 1-9

  Paramothayan, Shanthi ^a   Lasserson, Toby ^b  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Corticosteroids; Immunosuppressive and cytotoxic drugs; Pulmonary sarcoidosis; Systematic review

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; ETANERCEPT; FLUTICASONE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORFLURANE; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; THALIDOMIDE;

ASTHMA; CHEST INFECTION; COCHRANE LIBRARY; CORTICOSTEROID THERAPY; COUGHING; CUSHINGOID SYNDROME; DRUG EFFICACY; DYSPNEA; EVIDENCE BASED PRACTICE; FLUID RETENTION; FOLLOW UP; HOARSENESS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; MOUTH INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RASH; REVIEW; SARCOIDOSIS; SIDE EFFECT; SORE THROAT; THORAX RADIOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; CYTOTOXINS; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PULMONARY FIBROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 36348968294     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.08.010     Document Type: Review

References (25)

1. Sharma O.P. Sarcoidosis. Dis Mon 36 (1990) 469-535
2. Lynch J.P. Pulmonary sarcoidosis: current concepts and controversies. Compr Ther 23 (1997) 197-216
3. Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews, 2005, Issue 2.
4. Paramothayan NS, Lasserson TJ, Walters EH. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews, 2006, Issue 3.
5. Higgins J.P.T., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
6. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clin Trials 17 (1996) 1-12
7. Alberts C., Van der Mark T.W., and Jansen H.M. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J 8 (1995) 682-688
8. Baughman R.P., Iannuzzi M.C., Lower E.E., et al. Double blind randomized trial of inhaled fluticasone for acute symptomatic pulmonary sarcoidosis. Am J Respir Crit Care Med 163 5 Suppl (2001) A557
9. DuBois R.M., Greenhalgh P.M., Southcott A.M., et al. Randomized trial of inhaled fluticasone proprionate in chronic stable pulmonary sarcoidosis: a pilot study. Eur Respir J 13 (1999) 1345-1350
10. Erkkila S., Froseth B., Hellstrom P.E., et al. Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. Sarcoidosis 5 (1988) 106-110
11. Israel H.L., Fouts D.W., and Beggs R.A. A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 107 (1973) 609-614
12. James D.G., Carstairs L.S., Trowell J., and Sharma O.P. Treatment of sarcoidosis: report of a controlled therapeutic trial. Lancet 2 (1967) 526-528
13. Ludwig-Sengpiel A., Jaksztat E., Welker L., et al. Effect of beclomethasone diproprionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymhocytes in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 214-221
14. McGrath D.S., Wells A.U., Desai S.R., et al. Efficacy, safety and tolerability of 3 M HFA-134A beclomethasone diproprionate in pulmonary sarcoidosis. Am J Respir Crit Care Med 165 suppl 8 (2002) A495
15. Milman N., Graudal N., Grode G., and Munch E. No effect of high-dose inhaled corticosteroids in pulmonary sarcoidosis: a double-blind, placebo- controlled study. J Intern Med 236 (1994) 285-290
16. Pietinalho A., Tukiainen P., Haahtela T., et al. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis. A double-blind, placebo-controlled multicentre study. Chest 116 (1999) 424-431
17. Roth I., Ehrke A., Eule H., and Weinecke W. First report of a controlled clinical trial of prednisolone treatment of intrathoracic sarcoidosis (Erster Bericht Uber eine kontollierte Untersuchung zur Prednisolon-Behandlung der thoraklen Sarkoidose). Z Erkr Atmungsorgane 142 (1975) 49-58
18. Selroos O., and Sellergren T.L. Corticosteroid therapy of pulmonary sarcoidosis: a prospective evaluation of alternate day and daily dosage in Stage 2 disease. Scand J Respir Dis 60 (1979) 215-221
19. Zaki M.H., Lyons H.A., Leilop L., and Huang C.T. Corticosteroid therapy in sarcoidosis: a 5 year controlled follow-up study. N Y State J Med 87 (1987) 496-499
20. Baltzan M., Mehta S., Kirkham T., and Cosio M. Randomised trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 160 (1999) 192-197
21. Baughman R.P., Winget D., and Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 17 (2000) 60-66
22. British tuberculosis association (BTA) chloroquine in the treatment of sarcoidosis. Tubercle 48 (1967) 257-272
23. Manganiello VC, Park MK, Stylianou M, et al. A randomized trial of pentoxifylline in pulmonary sarcoidosis. In: American Thoracic Society 2005 international conference, May 20-25, San Diego, California, 2005, p. A14.
24. Wyser C., van Schalkwyk E., Alheit B., Bardin P., and Joubert J. Treatment of progressive pulmonary sarcoidosis with cyclosporine a: a RCT. Am J Respir Crit Care Med 157 (1997) 1371-1376
25. ATS/ERS/WASOG statement on Sarcoidosis. Eur Respir J 14 (1999) 735-737